T. Crook et al., High level expression of Delta N-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?, ONCOGENE, 19(30), 2000, pp. 3439-3444
Undifferentiated nasopharyngeal carcinoma (NPC) is an epithelial malignancy
that is consistently associated with Epstein-Barr virus (EBV) but which ve
ry rarely has p53 gene mutations in primary tumours, Since the tumour suppr
essor p53 is mutated in most human canters or the wild type protein is inac
tivated in a significant number of the remainder, here we have investigated
cellular factors that could compromise p53 function in primary NPC, Twenty
-five primary tumours were judged to carry only wild type p53 by SSCP analy
sis of all exons and sequence determination of exons 4-9, Only one tumour w
as found to express significant levels of hMdm2 and in 24/25 there were no
detectable mutations or deletions in exons 1 beta and 2 of the p14(ARF) gen
e. However, immunohistochemistry consistently revealed that all the tumour
cells express substantial amounts of the p53-related protein p63, Semi-quan
titative RT- PCR analysis of mRNA from tumour biopsies showed that the domi
nant species expressed was invariably the truncated Delta N-isotype. Since
this can block p53-mediated transactivation, it is potentially a dominant-n
egative isoform, In normal nasopharyngeal epithelium the distribution of p6
3 was restricted to the proliferating basal and suprabasal layers. We sugge
st that Delta N-p63 is a good candidate as a suppressor of wild type p53 fu
nction in these tumours and also that it may prove to be a valuable diagnos
tic marker for undifferentiated NPC.